Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population

Xiaolong Zhu; Runzhi Huang; Peng Hu; Penghui Yan; Suna Zhai; Jie Zhang; Junwei Zhuang; Huabin Yin; Tong Meng; Daoke Yang; Zongqiang Huang

doi:10.12659/MSM.929154

17 February 2021: Database Analysis

Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population

Xiaolong Zhu ^1BCDEF* , Runzhi Huang ^12ABCDEF* , Peng Hu ^1E* , Penghui Yan ^1ABCDEF , Suna Zhai ^3D , Jie Zhang ^2AE , Junwei Zhuang ^1F , Huabin Yin ^4E , Tong Meng ^4AF* , Daoke Yang ^3F* , Zongqiang Huang ^1AG*

DOI: 10.12659/MSM.929154

Med Sci Monit 2021; 27:e929154

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions Supplementary Data References

View HTML version

Figure 5 Hematoxylin and eosin (HE) slides and gross specimens of patients in the validation dataset with a histopathological diagnosis of malignant giant cell tumor of bone.

Back to the Article

Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population

Your Privacy